Form 4: Insmed Inc. Executive Michael Smith Reports Stock Transactions
SEC Form 4 Filing
Chief Legal Officer Michael Smith reports exercising stock options and selling shares of Insmed Inc. under a pre-arranged 10b5-1 trading plan.
Summary
- On September 13, 2024, Michael Smith, Chief Legal Officer of Insmed Inc., executed transactions involving the company's common stock.
- Smith exercised stock options to acquire 7,000 shares at a price of $22.76 per share.
- He then sold 18,871 shares at a weighted average price of $74.16, with prices ranging from $73.61 to $74.60.
- Additionally, he sold 9,000 shares at a weighted average price of $74.75, with prices ranging from $74.61 to $74.90.
- These transactions were conducted under a pre-arranged 10b5-1 trading plan.
- Following these transactions, Smith directly owns 67,856 shares of Insmed Inc. common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by an officer. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The use of a 10b5-1 trading plan suggests that these transactions were pre-planned and not based on any inside information.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the use of a 10b5-1 plan suggests the impact should be limited.
Key Dates
| Date | Description |
|---|---|
| 09/13/2024 | Date of stock option exercise and stock sales. |
| 09/16/2024 | Date of signature on the Form 4 filing. |
| 05/21/2025 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.